Very Low Carbohydrate Diet as an Adjunctive Therapy for Youth Type 1 Diabetes
2 other identifiers
interventional
6
1 country
1
Brief Summary
This prospective, open-label pilot/feasibility study of 10 youth with T1D is to evaluate glycemic and metabolic changes taking place with a very low carbohydrate diet.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jun 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 6, 2019
CompletedFirst Posted
Study publicly available on registry
September 9, 2019
CompletedStudy Start
First participant enrolled
June 25, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 20, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
February 20, 2022
CompletedResults Posted
Study results publicly available
June 5, 2023
CompletedFebruary 15, 2024
February 1, 2024
1.7 years
September 6, 2019
March 13, 2023
February 13, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Percentage of Time in Target Range of 70-180 mg/dL.
The target range is 70 mg/dL - 180 mg/dL based on sensor-derived glucose levels. The outcome is reflected as the percentage of time spent in this range during the time frame.
2 weeks per intervention, up to 7 weeks
Secondary Outcomes (6)
Percentage of Time Spent > 180 mg/dL to 250 mg/dl
2 weeks per intervention, up to 7 weeks
Percent Time Spent > 250 mg/dL Based on Sensor-derived Glucose Values
2 weeks per intervention, up to 7 weeks
Percent of Time Spent > = 55 to < 70 mg/dL Based on Sensor-derived Glucose Values
2 weeks per intervention, up to 7 weeks
Percent Time Spent < 55 mg/dL Based on Sensor-derived Glucose Values
2 weeks per intervention, up to 7 weeks
Total Daily Insulin Dose
2 weeks per intervention, up to 7 weeks
- +1 more secondary outcomes
Study Arms (1)
Very Low Carbohydrate Diet
EXPERIMENTALParticipants will follow a high protein very low carbohydrate diet (VLCD) for 2 weeks. This will be 11% of caloric intake from carbohydrates, 54% of calories from protein, and 35% of calories from fat. Immediately following this, participants will follow a high protein very low carbohydrate diet (VLCD) which will be 11% of caloric intake from carbohydrates, 23% of calories from protein, and 66% of calories from fat.
Interventions
A very low carbohydrate diet (VLCD), is defined as limiting carbohydrate intake to 11% of total daily caloric intake.
Eligibility Criteria
You may qualify if:
- BMI 19-30 m2 for individuals at least 18 years old or BMI \< 95 percentile for individuals less than 18 years old
- Participants 18 years of age must be able to read and provide written consent
- Participants under 18 years of age must be able to read and provide written assent
- Participants are managed using an insulin pump or injections
- Participant has or is willing to wear a CGM for the duration of the study
- Participant is willing to complete diet logging procedures stated above
You may not qualify if:
- A1c \< 6.5% or \> 10%
- Recent history of more than 1 of diabetic ketoacidosis (DKA) in the past 6 months
- Treatment with glucose-lowering drugs other than insulin
- Unstable psychiatric disorders, including eating disorders (DSM-V criteria)
- Weight loss medications within the last 6 months
- Females who are pregnant, lactating or planning to become pregnant in the next 6 months
- Another medical condition that precludes participation in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Yale-New Haven Hospital
New Haven, Connecticut, 06511, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Laura Marie Nally, MD
- Organization
- Yale School of Medicine
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SEQUENTIAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 6, 2019
First Posted
September 9, 2019
Study Start
June 25, 2020
Primary Completion
February 20, 2022
Study Completion
February 20, 2022
Last Updated
February 15, 2024
Results First Posted
June 5, 2023
Record last verified: 2024-02
Data Sharing
- IPD Sharing
- Will not share